Age related changes in lens transport and cataract
Age related changes in lens transport and cataract
批准号:
9319323
负责人:
THOMAS W WHITE
金额:
$41.18万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-08-01 至 2021-07-31
关键词:
AffectAgeAge of OnsetAgingAging-Related ProcessAgonistAmericanAnimal ModelAnimalsBiologicalBiological MarkersBlindnessBlood CirculationCarrier ProteinsCataractCataract ExtractionCattleClinicalClinical TrialsClinical assessmentsConnexinsDevelopmentElderlyEnzymesExpenditureFailureFutureGenesGeometryGoalsHealthcareHealthcare SystemsHomeostasisHumanHuman VolunteersHydrostatic PressureImageIn SituIn VitroIndividualInterventionIon ChannelIonsKnowledgeLeadMagnetic Resonance ImagingMapsMeasurementMeasuresMediatingMedicalMedicareMethodologyMethodsMicrocirculationMolecularMonitorMusMutationNa(+)-K(+)-Exchanging ATPaseOperative Surgical ProceduresOpticsPathologicPathway interactionsPharmacologyPhosphoric Monoester HydrolasesPhosphotransferasesPhysiologyPopulationProcessPropertyProteinsProtocols documentationReagentRefractive IndicesRisk FactorsRoleSignal PathwaySignal TransductionSurfaceSystemTestingTherapeuticTherapeutic InterventionTraumaTreatment EfficacyUltraviolet RaysVisionVisual AcuityWaterWorld Health Organizationage relateddesignefficacy testinghealthy volunteerhuman subjectimaging modalityin vitro Assayin vivoinhibitor/antagonistinsightlenslens transparencynovelnovel therapeutic interventionnovel therapeuticspreventprotein transportpublic health relevanceresearch clinical testingwater channel
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
Cataract is the leading cause of blindness worldwide and the most common risk factor for human cataract is
simply aging. The World Health Organization has identified cataract as a cause of vision loss in one of six
Americans over the age of 40, and half of Americans older than 80. It is our hypothesis that the process of
aging has negative effects on lens transport, degrading ion and water homeostasis, and producing changes in
lens water content. This age-dependent decline in water transport alters the optical properties of the lens,
initially causing changes in vision that ultimately manifest as cataract and eventually require surgical
correction. To identify potentially novel anti-cataract therapies, our strategy will be to study the pathways that
regulate the transport proteins that generate the micro-circulation system that maintains the water content and
optical properties of the lens. The future clinical testing of any therapeutic interventions identified will require
methods to longitudinally monitor the water transport status and optical properties of the human lens in vivo. To
enable clinical assessment in healthy volunteer subjects and allow early biomarkers of pathological changes in
water transport to be detected, we will develop Magnetic Resonance Imaging methodologies to non-invasively
track the optical properties of the human lens. To achieve these goals, we will identify mechanisms that
regulate activity of the specific molecular components of lens transport in vitro. We will then identify
pharmacological interventions that regulate transport activity in the intact lens ex vivo. We will also use
Magnetic Resonance Imaging (MRI) to spatially map the effect changing lens water transport has on total free
water content, the water to protein ratio (refractive index) and lens surface geometry in the presence and
absence of pharmacological modifiers of transport. Finally, we will develop new MRI imaging protocols to be
able to monitor key parameters of lens transport longitudinally in volunteer human subjects. These proposed
studies have the potential to not only reveal possible therapeutic pathways to delay the onset of cataract, but
also the imaging methods required for future tests of the efficacy of these strategies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Age related changes in lens transport and cataract
-
批准号:10475686
-
项目类别:
-
资助金额:$33.68万
-
财政年份:2016
-
负责人:THOMAS W WHITE
-
依托单位:
Age related changes in lens transport and cataract
-
批准号:10678844
-
项目类别:
-
资助金额:$34.73万
-
财政年份:2016
-
负责人:THOMAS W WHITE
-
依托单位:
Age related changes in lens transport and cataract
-
批准号:10295389
-
项目类别:
-
资助金额:$36.21万
-
财政年份:2016
-
负责人:THOMAS W WHITE
-
依托单位:
Cx26 mutations in syndromic deafness linked to skin disease
-
批准号:8230659
-
项目类别:
-
资助金额:$33.7万
-
财政年份:2010
-
负责人:THOMAS W WHITE
-
依托单位:
Cx26 mutations in syndromic deafness linked to skin disease
-
批准号:7861467
-
项目类别:
-
资助金额:$36.41万
-
财政年份:2010
-
负责人:THOMAS W WHITE
-
依托单位:
Cx26 mutations in syndromic deafness linked to skin disease
-
批准号:8034257
-
项目类别:
-
资助金额:$33.67万
-
财政年份:2010
-
负责人:THOMAS W WHITE
-
依托单位:
Cx26 mutations in syndromic deafness linked to skin disease
-
批准号:8438425
-
项目类别:
-
资助金额:$32.04万
-
财政年份:2010
-
负责人:THOMAS W WHITE
-
依托单位:
Connexin mutations in deafness
-
批准号:7027008
-
项目类别:
-
资助金额:$26.75万
-
财政年份:2004
-
负责人:THOMAS W WHITE
-
依托单位:
Connexin mutations in deafness
-
批准号:7195040
-
项目类别:
-
资助金额:$25.97万
-
财政年份:2004
-
负责人:THOMAS W WHITE
-
依托单位:
Connexin mutations in deafness
-
批准号:7371879
-
项目类别:
-
资助金额:$25.63万
-
财政年份:2004
-
负责人:THOMAS W WHITE
-
依托单位:
Connexin mutations in deafness
-
批准号:6857085
-
项目类别:
-
资助金额:$27.39万
-
财政年份:2004
-
负责人:THOMAS W WHITE
-
依托单位:
Connexin mutations in deafness
-
批准号:6761467
-
项目类别:
-
资助金额:$27.39万
-
财政年份:2004
-
负责人:THOMAS W WHITE
-
依托单位:
Connexin Mutations in Deafness
-
批准号:6488071
-
项目类别:
-
资助金额:$7.53万
-
财政年份:2002
-
负责人:THOMAS W WHITE
-
依托单位:
Connexin Mutations in Deafness
-
批准号:6626291
-
项目类别:
-
资助金额:$7.53万
-
财政年份:2002
-
负责人:THOMAS W WHITE
-
依托单位:
Lens intercellular communication, connexins and cataract
-
批准号:7029275
-
项目类别:
-
资助金额:$34.76万
-
财政年份:2000
-
负责人:THOMAS W WHITE
-
依托单位:
Lens intercellular communication, connexins and cataract
-
批准号:7582385
-
项目类别:
-
资助金额:$33.86万
-
财政年份:2000
-
负责人:THOMAS W WHITE
-
依托单位:
Lens intercellular communication connexins and cataract
-
批准号:8585065
-
项目类别:
-
资助金额:$40.75万
-
财政年份:2000
-
负责人:THOMAS W WHITE
-
依托单位:
Lens intercellular communication connexins and cataract
-
批准号:8248856
-
项目类别:
-
资助金额:$42.22万
-
财政年份:2000
-
负责人:THOMAS W WHITE
-
依托单位:
Lens intercellular communication, connexins and cataract
-
批准号:7194166
-
项目类别:
-
资助金额:$33.86万
-
财政年份:2000
-
负责人:THOMAS W WHITE
-
依托单位:
Lens intercellular communication connexins and cataract
-
批准号:8776304
-
项目类别:
-
资助金额:$40.82万
-
财政年份:2000
-
负责人:THOMAS W WHITE
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: